Pan-Canadian bulk drug buying plan announcedCPhA offers to work with premiers to ensure program benefits patients Abrupt Stop: Discontinuation syndromeManaging discontinuation syndrome associated with psychoactive medications. Tech regulation moving forward BC College unlikely to back away from regulation, despite petition signed by 500 pharmacists. Clinical Notes: Triptan safety in pregnancy Exposure to sumatriptan during pregnancy does not appear increase risk of birth defects: study Dealing with grievances under new regulations With regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). Drug News: Finacea, FluMist, Intanza Finacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Editorial: How do you like your innovation? In these uncertain times, be open to new ideas, wherever they originate. Editorial: What’s on your horizon? The forest of opportunity is lush as pharmacy transitions to patient-centred practice. Letter: What do pharmacists want? Why are we providing our professional services for less than it costs to cover our expenses? Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. Making the grade Tech takes on teaching duties. Medication Forum: SGLT2 inhibitors for type 2 diabetes The potential role of SGLT2 inhibitors in the management of type 2 diabetes. First Previous 938 939 940 941 942 Next Last
